NEW YORK, March 12 – The ability to identify and assess SNPs will help to increase treatment efficacy and reduce adverse drug reactions, helping to save the healthcare industry more than $1 billion over the next decade, a survey released Monday by Front Line Strategic Management Consulting said.

The Foster City, Calif.-based consultancy said that treatment efficacy could increase by 32 percent over current levels while adverse drug reactions could be reduced by up to 25 percent.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.